Fig. 6From: Development of a multivariable improvement measure for goutPercentage of subjects with GMIM20, 50, and 70 responses during the OLE for patients who were treated with placebo in the RCT and biweekly pegloticase in the OLE. a Results for all GMIM criteria including urate < 6 mg/dL and b Results for all criteria excluding urate < 6.0 mg/dLBack to article page